BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Pistore C, Giannoni E, Colangelo T, Rizzo F, Magnani E, Muccillo L, Giurato G, Mancini M, Rizzo S, Riccardi M, Sahnane N, Del Vescovo V, Kishore K, Mandruzzato M, Macchi F, Pelizzola M, Denti MA, Furlan D, Weisz A, Colantuoni V, Chiarugi P, Bonapace IM. DNA methylation variations are required for epithelial-to-mesenchymal transition induced by cancer-associated fibroblasts in prostate cancer cells. Oncogene. 2017;36:5551-5566. [PMID: 28581528 DOI: 10.1038/onc.2017.159] [Cited by in Crossref: 44] [Cited by in F6Publishing: 54] [Article Influence: 8.8] [Reference Citation Analysis]
Number Citing Articles
1 Feng B, Wu J, Shen B, Jiang F, Feng J. Cancer-associated fibroblasts and resistance to anticancer therapies: status, mechanisms, and countermeasures. Cancer Cell Int 2022;22:166. [PMID: 35488263 DOI: 10.1186/s12935-022-02599-7] [Reference Citation Analysis]
2 Lee MK, Brown MS, Wilkins OM, Pattabiraman DR, Christensen BC. Distinct cytosine modification profiles define epithelial-to-mesenchymal cell-state transitions. Epigenomics 2022. [PMID: 35382559 DOI: 10.2217/epi-2022-0023] [Reference Citation Analysis]
3 De P, Aske J, Sulaiman R, Dey N. Bête Noire of Chemotherapy and Targeted Therapy: CAF-Mediated Resistance. Cancers 2022;14:1519. [DOI: 10.3390/cancers14061519] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Qiao L, Chen Y, Liang N, Xie J, Deng G, Chen F, Wang X, Liu F, Li Y, Zhang J. Targeting Epithelial-to-Mesenchymal Transition in Radioresistance: Crosslinked Mechanisms and Strategies. Front Oncol 2022;12:775238. [PMID: 35251963 DOI: 10.3389/fonc.2022.775238] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
5 Hao X, Sun G, Zhang Y, Kong X, Rong D, Song J, Tang W, Wang X. Targeting Immune Cells in the Tumor Microenvironment of HCC: New Opportunities and Challenges. Front Cell Dev Biol 2021;9:775462. [PMID: 34869376 DOI: 10.3389/fcell.2021.775462] [Cited by in F6Publishing: 8] [Reference Citation Analysis]
6 Chaves LP, Melo CM, Saggioro FP, Reis RBD, Squire JA. Epithelial–Mesenchymal Transition Signaling and Prostate Cancer Stem Cells: Emerging Biomarkers and Opportunities for Precision Therapeutics. Genes 2021;12:1900. [DOI: 10.3390/genes12121900] [Reference Citation Analysis]
7 Han L, Wang S, Wei C, Fang Y, Huang S, Yin T, Xiong B, Yang C. Tumour microenvironment: a non-negligible driver for epithelial-mesenchymal transition in colorectal cancer. Expert Rev Mol Med 2021;23:e16. [PMID: 34758892 DOI: 10.1017/erm.2021.13] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
8 Han J, Yun J, Quan M, Kang W, Jung JG, Heo W, Li S, Lee KJ, Son HY, Kim JH, Choi J, Noh DY, Na D, Ryu HS, Lee C, Kim JI, Moon HG. JAK2 regulates paclitaxel resistance in triple negative breast cancers. J Mol Med (Berl) 2021;99:1783-95. [PMID: 34626199 DOI: 10.1007/s00109-021-02138-3] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
9 Brabletz S, Schuhwerk H, Brabletz T, Stemmler MP. Dynamic EMT: a multi-tool for tumor progression. EMBO J 2021;40:e108647. [PMID: 34459003 DOI: 10.15252/embj.2021108647] [Cited by in Crossref: 2] [Cited by in F6Publishing: 44] [Article Influence: 2.0] [Reference Citation Analysis]
10 Legge D, Li L, Moriarty W, Lee D, Szemes M, Zahed A, Panousopoulos L, Chung WY, Aghabi Y, Barratt J, Williams R, Pritchard-Jones K, Malik KTA, Oltean S, Brown KW. The epithelial splicing regulator ESRP2 is epigenetically repressed by DNA hypermethylation in Wilms tumour and acts as a tumour suppressor. Mol Oncol 2021. [PMID: 34520622 DOI: 10.1002/1878-0261.13101] [Reference Citation Analysis]
11 Dai YH, Wang YF, Shen PC, Lo CH, Yang JF, Lin CS, Chao HL, Huang WY. Gene-associated methylation status of ST14 as a predictor of survival and hormone receptor positivity in breast Cancer. BMC Cancer 2021;21:945. [PMID: 34418985 DOI: 10.1186/s12885-021-08645-3] [Reference Citation Analysis]
12 Batsché E, Yi J, Mauger O, Kornobis E, Hopkins B, Hanmer-Lloyd C, Muchardt C. CD44 alternative splicing senses intragenic DNA methylation in tumors via direct and indirect mechanisms. Nucleic Acids Res 2021;49:6213-37. [PMID: 34086943 DOI: 10.1093/nar/gkab437] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
13 Cheng W, Cao J, Xia Y, Lei X, Wu L, Shi L. A DNA methylation profile of long non-coding RNAs can predict OS in prostate cancer. Bioengineered 2021;12:3252-62. [PMID: 34238128 DOI: 10.1080/21655979.2021.1945991] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
14 Papanikolaou S, Vourda A, Syggelos S, Gyftopoulos K. Cell Plasticity and Prostate Cancer: The Role of Epithelial-Mesenchymal Transition in Tumor Progression, Invasion, Metastasis and Cancer Therapy Resistance. Cancers (Basel) 2021;13:2795. [PMID: 34199763 DOI: 10.3390/cancers13112795] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
15 Ni Y, Zhou X, Yang J, Shi H, Li H, Zhao X, Ma X. The Role of Tumor-Stroma Interactions in Drug Resistance Within Tumor Microenvironment. Front Cell Dev Biol 2021;9:637675. [PMID: 34095111 DOI: 10.3389/fcell.2021.637675] [Cited by in F6Publishing: 18] [Reference Citation Analysis]
16 Wei W, Li QG, Long X, Hu GH, He HJ, Huang YB, Yi XL. Sarcomatoid carcinoma of the prostate with bladder invasion shortly after androgen deprivation: Two case reports. World J Clin Cases 2021; 9(7): 1668-1675 [PMID: 33728311 DOI: 10.12998/wjcc.v9.i7.1668] [Reference Citation Analysis]
17 Li S, Wang L, Zhao Q, Wang Z, Lu S, Kang Y, Jin G, Tian J. Genome-Wide Analysis of Cell-Free DNA Methylation Profiling for the Early Diagnosis of Pancreatic Cancer. Front Genet 2020;11:596078. [PMID: 33424927 DOI: 10.3389/fgene.2020.596078] [Cited by in Crossref: 2] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
18 Kheirandish S, Eshghyar N, Yazdani F, Amini Shakib P, Hosseini-Bereshneh A, Nouri Z, Kheiran-Dish A, Karami F. Methylation Assessment of Two DKK2 and DKK4 Genes in Oral Squamous Cell Carcinoma Patients. Iran J Public Health 2020;49:1947-53. [PMID: 33346226 DOI: 10.18502/ijph.v49i10.4698] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
19 Ili C, Buchegger K, Demond H, Castillo-Fernandez J, Kelsey G, Zanella L, Abanto M, Riquelme I, López J, Viscarra T, García P, Bellolio E, Saavedra D, Brebi P. Landscape of Genome-Wide DNA Methylation of Colorectal Cancer Metastasis. Cancers (Basel) 2020;12:E2710. [PMID: 32971738 DOI: 10.3390/cancers12092710] [Cited by in Crossref: 3] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
20 Jena BC, Das CK, Bharadwaj D, Mandal M. Cancer associated fibroblast mediated chemoresistance: A paradigm shift in understanding the mechanism of tumor progression. Biochim Biophys Acta Rev Cancer 2020;1874:188416. [PMID: 32822826 DOI: 10.1016/j.bbcan.2020.188416] [Cited by in Crossref: 7] [Cited by in F6Publishing: 14] [Article Influence: 3.5] [Reference Citation Analysis]
21 Gambelunghe A, Giovagnoli S, Di Michele A, Boncompagni S, Dell'Omo M, Leopold K, Iavicoli I, Talesa VN, Antognelli C. Redox-Sensitive Glyoxalase 1 Up-Regulation Is Crucial for Protecting Human Lung Cells from Gold Nanoparticles Toxicity. Antioxidants (Basel) 2020;9:E697. [PMID: 32756399 DOI: 10.3390/antiox9080697] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
22 Nie Y, Ding Y, Yang M. GRHL2 Upregulation Predicts a Poor Prognosis and Promotes the Resistance of Serous Ovarian Cancer to Cisplatin. Onco Targets Ther 2020;13:6303-14. [PMID: 32636649 DOI: 10.2147/OTT.S250412] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
23 Yi H, Li G, Long Y, Liang W, Cui H, Zhang B, Tan Y, Li Y, Shen L, Deng D, Tang Y, Mao C, Tian S, Cai Y, Zhu Q, Hu Y, Chen W, Fang L. Integrative multi-omics analysis of a colon cancer cell line with heterogeneous Wnt activity revealed RUNX2 as an epigenetic regulator of EMT. Oncogene 2020;39:5152-64. [PMID: 32535615 DOI: 10.1038/s41388-020-1351-z] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 5.5] [Reference Citation Analysis]
24 Rajić J, Dinić S, Uskoković A, Arambašić Jovanović J, Tolić A, Đorđević M, Đorđević M, Poznanović G, Mihailović M, Inic-Kanada A, Barisani-Asenbauer T, Grdović N, Vidaković M. DNA methylation of miR-200 clusters promotes epithelial to mesenchymal transition in human conjunctival epithelial cells. Exp Eye Res 2020;197:108047. [PMID: 32387379 DOI: 10.1016/j.exer.2020.108047] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
25 Cortés-hernández LE, Eslami-s Z, Alix-panabières C. Circulating tumor cell as the functional aspect of liquid biopsy to understand the metastatic cascade in solid cancer. Molecular Aspects of Medicine 2020;72:100816. [DOI: 10.1016/j.mam.2019.07.008] [Cited by in Crossref: 27] [Cited by in F6Publishing: 37] [Article Influence: 13.5] [Reference Citation Analysis]
26 Kaur J, Daoud A, Eblen ST. Targeting Chromatin Remodeling for Cancer Therapy. Curr Mol Pharmacol. 2019;12:215-229. [PMID: 30767757 DOI: 10.2174/1874467212666190215112915] [Cited by in Crossref: 13] [Cited by in F6Publishing: 16] [Article Influence: 6.5] [Reference Citation Analysis]
27 Lawrence MG, Pidsley R, Niranjan B, Papargiris M, Pereira BA, Richards M, Teng L, Norden S, Ryan A, Frydenberg M, Stirzaker C, Taylor RA, Risbridger GP, Clark SJ. Alterations in the methylome of the stromal tumour microenvironment signal the presence and severity of prostate cancer. Clin Epigenetics 2020;12:48. [PMID: 32188493 DOI: 10.1186/s13148-020-00836-2] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
28 Cong X, Zhang Y, Zhu Z, Li S, Yin X, Zhai Z, Zhang Y, Xue Y. CD66b+ neutrophils and α-SMA+ fibroblasts predict clinical outcomes and benefits from postoperative chemotherapy in gastric adenocarcinoma. Cancer Med 2020;9:2761-73. [PMID: 32096331 DOI: 10.1002/cam4.2939] [Cited by in Crossref: 1] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
29 Pietrovito L, Iozzo M, Bacci M, Giannoni E, Chiarugi P. Treatment with Cannabinoids as a Promising Approach for Impairing Fibroblast Activation and Prostate Cancer Progression. Int J Mol Sci 2020;21:E787. [PMID: 31991773 DOI: 10.3390/ijms21030787] [Cited by in Crossref: 5] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
30 Reese RM, Harrison MM, Alarid ET. Grainyhead-like Protein 2: The Emerging Role in Hormone-Dependent Cancers and Epigenetics. Endocrinology 2019;160:1275-88. [PMID: 30958537 DOI: 10.1210/en.2019-00213] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
31 Dongre A, Weinberg RA. New insights into the mechanisms of epithelial-mesenchymal transition and implications for cancer. Nat Rev Mol Cell Biol. 2019;20:69-84. [PMID: 30459476 DOI: 10.1038/s41580-018-0080-4] [Cited by in Crossref: 762] [Cited by in F6Publishing: 1145] [Article Influence: 254.0] [Reference Citation Analysis]
32 Li D, Yun Y, Gao R. Oxygenated Polycyclic aromatic hydrocarbons (Oxy-PAHs) facilitate lung cancer metastasis by epigenetically regulating the epithelial-to-mesenchymal transition (EMT). Environmental Pollution 2019;255:113261. [DOI: 10.1016/j.envpol.2019.113261] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
33 Di Zazzo E, Galasso G, Giovannelli P, Di Donato M, Bilancio A, Perillo B, Sinisi AA, Migliaccio A, Castoria G. Estrogen Receptors in Epithelial-Mesenchymal Transition of Prostate Cancer. Cancers (Basel) 2019;11:E1418. [PMID: 31548498 DOI: 10.3390/cancers11101418] [Cited by in Crossref: 18] [Cited by in F6Publishing: 23] [Article Influence: 6.0] [Reference Citation Analysis]
34 Chung VY, Tan TZ, Ye J, Huang RL, Lai HC, Kappei D, Wollmann H, Guccione E, Huang RY. The role of GRHL2 and epigenetic remodeling in epithelial-mesenchymal plasticity in ovarian cancer cells. Commun Biol 2019;2:272. [PMID: 31372511 DOI: 10.1038/s42003-019-0506-3] [Cited by in Crossref: 25] [Cited by in F6Publishing: 29] [Article Influence: 8.3] [Reference Citation Analysis]
35 Barajas-Olmos FM, Ortiz-Sánchez E, Imaz-Rosshandler I, Córdova-Alarcón EJ, Martínez-Tovar A, Villanueva-Toledo J, Morales-Marín ME, Cruz-Colín JL, Rangel C, Orozco L, Centeno F. Analysis of the dynamic aberrant landscape of DNA methylation and gene expression during arsenic-induced cell transformation. Gene 2019;711:143941. [PMID: 31242453 DOI: 10.1016/j.gene.2019.143941] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 3.7] [Reference Citation Analysis]
36 Di Donato M, Cernera G, Migliaccio A, Castoria G. Nerve Growth Factor Induces Proliferation and Aggressiveness In Prostate Cancer Cells. Cancers (Basel) 2019;11:E784. [PMID: 31174415 DOI: 10.3390/cancers11060784] [Cited by in Crossref: 18] [Cited by in F6Publishing: 31] [Article Influence: 6.0] [Reference Citation Analysis]
37 Trino S, Zoppoli P, Carella AM, Laurenzana I, Weisz A, Memoli D, Calice G, La Rocca F, Simeon V, Savino L, Del Vecchio L, Musto P, Caivano A, De Luca L. DNA methylation dynamic of bone marrow hematopoietic stem cells after allogeneic transplantation. Stem Cell Res Ther 2019;10:138. [PMID: 31109375 DOI: 10.1186/s13287-019-1245-6] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
38 Hu J, Yu Y. Epigenetic response profiles into environmental epigenotoxicant screening and health risk assessment: A critical review. Chemosphere 2019;226:259-72. [PMID: 30933735 DOI: 10.1016/j.chemosphere.2019.03.096] [Cited by in Crossref: 21] [Cited by in F6Publishing: 26] [Article Influence: 7.0] [Reference Citation Analysis]
39 Chen Y, Wen H, Zhou C, Su Q, Lin Y, Xie Y, Huang Y, Qiu Q, Lin J, Huang X, Tan W, Min C, Wang C. TNF-α derived from M2 tumor-associated macrophages promotes epithelial-mesenchymal transition and cancer stemness through the Wnt/β-catenin pathway in SMMC-7721 hepatocellular carcinoma cells. Exp Cell Res 2019;378:41-50. [PMID: 30844387 DOI: 10.1016/j.yexcr.2019.03.005] [Cited by in Crossref: 35] [Cited by in F6Publishing: 47] [Article Influence: 11.7] [Reference Citation Analysis]
40 Kadel D, Zhang Y, Sun HR, Zhao Y, Dong QZ, Qin LX. Current perspectives of cancer-associated fibroblast in therapeutic resistance: potential mechanism and future strategy. Cell Biol Toxicol 2019;35:407-21. [PMID: 30680600 DOI: 10.1007/s10565-019-09461-z] [Cited by in Crossref: 24] [Cited by in F6Publishing: 27] [Article Influence: 8.0] [Reference Citation Analysis]
41 Wang Y, Zong X, Mitra S, Mitra AK, Matei D, Nephew KP. IL-6 mediates platinum-induced enrichment of ovarian cancer stem cells. JCI Insight 2018;3:122360. [PMID: 30518684 DOI: 10.1172/jci.insight.122360] [Cited by in Crossref: 43] [Cited by in F6Publishing: 47] [Article Influence: 10.8] [Reference Citation Analysis]
42 Ippolito L, Morandi A, Giannoni E, Chiarugi P. Lactate: A Metabolic Driver in the Tumour Landscape. Trends Biochem Sci 2019;44:153-66. [PMID: 30473428 DOI: 10.1016/j.tibs.2018.10.011] [Cited by in Crossref: 82] [Cited by in F6Publishing: 128] [Article Influence: 20.5] [Reference Citation Analysis]
43 Polusani SR, Huang YW, Huang G, Chen CW, Wang CM, Lin LL, Osmulski P, Lucio ND, Liu L, Hsu YT, Zhou Y, Lin CL, Aguilera-Barrantes I, Valente PT, Kost ER, Chen CL, Shim EY, Lee SE, Ruan J, Gaczynska ME, Yan P, Goodfellow PJ, Mutch DG, Jin VX, Nicholson BJ, Huang TH, Kirma NB. Adipokines Deregulate Cellular Communication via Epigenetic Repression of Gap Junction Loci in Obese Endometrial Cancer. Cancer Res 2019;79:196-208. [PMID: 30389702 DOI: 10.1158/0008-5472.CAN-18-1615] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
44 Chang YW, Singh KP. Arsenic induces fibrogenic changes in human kidney epithelial cells potentially through epigenetic alterations in DNA methylation. J Cell Physiol 2019;234:4713-25. [PMID: 30191986 DOI: 10.1002/jcp.27244] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 3.0] [Reference Citation Analysis]
45 Klymenko Y, Nephew KP. Epigenetic Crosstalk between the Tumor Microenvironment and Ovarian Cancer Cells: A Therapeutic Road Less Traveled. Cancers (Basel) 2018;10:E295. [PMID: 30200265 DOI: 10.3390/cancers10090295] [Cited by in Crossref: 24] [Cited by in F6Publishing: 28] [Article Influence: 6.0] [Reference Citation Analysis]
46 Skvortsov S, Skvortsova II, Tang DG, Dubrovska A. Concise Review: Prostate Cancer Stem Cells: Current Understanding. Stem Cells 2018;36:1457-74. [PMID: 29845679 DOI: 10.1002/stem.2859] [Cited by in Crossref: 44] [Cited by in F6Publishing: 52] [Article Influence: 11.0] [Reference Citation Analysis]
47 Chen Y, Tan W, Wang C. Tumor-associated macrophage-derived cytokines enhance cancer stem-like characteristics through epithelial-mesenchymal transition. Onco Targets Ther 2018;11:3817-26. [PMID: 30013362 DOI: 10.2147/OTT.S168317] [Cited by in Crossref: 36] [Cited by in F6Publishing: 44] [Article Influence: 9.0] [Reference Citation Analysis]
48 Thongchot S, Ferraresi A, Vidoni C, Loilome W, Yongvanit P, Namwat N, Isidoro C. Resveratrol interrupts the pro-invasive communication between cancer associated fibroblasts and cholangiocarcinoma cells. Cancer Lett. 2018;430:160-171. [PMID: 29802929 DOI: 10.1016/j.canlet.2018.05.031] [Cited by in Crossref: 29] [Cited by in F6Publishing: 40] [Article Influence: 7.3] [Reference Citation Analysis]
49 Cui H, Hu Y, Guo D, Zhang A, Gu Y, Zhang S, Zhao C, Gong P, Shen X, Li Y, Wu H, Wang L, Zhao Z, Fan H. DNA methyltransferase 3A isoform b contributes to repressing E-cadherin through cooperation of DNA methylation and H3K27/H3K9 methylation in EMT-related metastasis of gastric cancer. Oncogene. 2018;37:4358-4371. [PMID: 29717263 DOI: 10.1038/s41388-018-0285-1] [Cited by in Crossref: 25] [Cited by in F6Publishing: 34] [Article Influence: 6.3] [Reference Citation Analysis]
50 Dittmer A, Dittmer J. Long-term exposure to carcinoma-associated fibroblasts makes breast cancer cells addictive to integrin β1. Oncotarget 2018;9:22079-94. [PMID: 29774124 DOI: 10.18632/oncotarget.25183] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
51 Cheng Y, Li H, Deng Y, Tai Y, Zeng K, Zhang Y, Liu W, Zhang Q, Yang Y. Cancer-associated fibroblasts induce PDL1+ neutrophils through the IL6-STAT3 pathway that foster immune suppression in hepatocellular carcinoma. Cell Death Dis. 2018;9:422. [PMID: 29556041 DOI: 10.1038/s41419-018-0458-4] [Cited by in Crossref: 82] [Cited by in F6Publishing: 141] [Article Influence: 20.5] [Reference Citation Analysis]
52 Zhang Q, Yang J, Bai J, Ren J. Reverse of non-small cell lung cancer drug resistance induced by cancer-associated fibroblasts via a paracrine pathway. Cancer Sci 2018;109:944-55. [PMID: 29383798 DOI: 10.1111/cas.13520] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 4.3] [Reference Citation Analysis]
53 Assenov Y, Brocks D, Gerhäuser C. Intratumor heterogeneity in epigenetic patterns. Semin Cancer Biol 2018;51:12-21. [PMID: 29366906 DOI: 10.1016/j.semcancer.2018.01.010] [Cited by in Crossref: 32] [Cited by in F6Publishing: 35] [Article Influence: 8.0] [Reference Citation Analysis]
54 Zhou LL, Ni J, Feng WT, Yao R, Yue S, Zhu YN, Tang HY, Lv LY, Feng JF, Zhu WG. High YBX1 expression indicates poor prognosis and promotes cell migration and invasion in nasopharyngeal carcinoma. Exp Cell Res. 2017;361:126-134. [PMID: 29024700 DOI: 10.1016/j.yexcr.2017.10.009] [Cited by in Crossref: 19] [Cited by in F6Publishing: 25] [Article Influence: 3.8] [Reference Citation Analysis]